Acute Myeloid Leukemia (AML)

ASH 2021 MDS and AML - for Patients

Thumbnail - ASH 2021 MDS and AML for Patients

This publication offers summaries of selected abstracts presented at the December 2021 Meeting of the American Hematology Society. It provides new and updated information about new research into the diagnosis, treatment…

ASH 2022 MDS and AML - Booklet

Thumbnail - MDS and AML Research Summaries for Patients - ASH 2022

This publication offers summaries of selected abstracts presented at the Annual Meeting of the American Hematology Society held in December 2022. It provides new and updated information about research into the diagnosis…

Blood and Bone Marrow Basics

Thumbnail - Blood and Bone Marrow Basics

A patient's guide to understanding blood and bone marrow. Blood is a "circulating organ" of the body. It is composed of many different types of cells that are carried through the body in plasma. The blood helps to…

Community Connections

Thumbnail - Community Connections

Would you like to connect with other patients and families in your own town? Learn how you can participate in our volunteer-led Community Connections-local groups designed to inspire the creation of community…

Find a Specialist

Thumbnail - Find a Specialist

A bone marrow failure diagnosis of aplastic anemia, MDS and PNH is complicated, and the treatment options require oversight by a well-trained and experienced expert. But, finding an expert can be challenging. AAMDS has…

Eileen Hu, MD, PhD

Institution
UT Southwestern Medical Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Dr. Eileen Hu is an internal medicine specialist located in Dallas, TX, who completed her education at Ohio State University College of Medicine in 2022 and is currently undergoing her residency in internal medicine at the University of Texas Southwestern Medical Center, projected to finish in 2028. She has contributed to several publications focusing on leukemia, including works in Nature Genetics, Cell Reports, and Blood, with citations indicating engagement from the scientific community. Her research primarily revolves around acute myeloid leukemia, drug sensitivities, and cellular

Jamie L Koprivnikar, MD

Institution
John Theurer Cancer Center - Hackensack
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Dr. Jamie Koprvinikar specializes in hematology and medical oncology and is board certified in both. She also holds a board certification in internal medicine. Dr. Koprivnikar received her medical degree from the Sidney Kimmel Medical College, formerly Jefferson Medical College of Thomas Jefferson University, in Philadelphia, PA. She completed her internal medicine residency at MedStar Georgetown University Medical Center in Washington, DC. She then completed a fellowship in hematology and oncology, also at MedStar Georgetown University Medical Center. She was chosen to serve as chief fellow

Clayton Jackson, MD

Institution
UT Southwestern Medical Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
Clayton Jackson, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He specializes in hematology and oncology. Dr. Jackson earned his medical degree at the Medical College of Georgia. He completed a residency in internal medicine and gained advanced training through a fellowship in hematology and oncology at Atrium Health Wake Forest Baptist Medical Center. He received advanced cellular therapy and bone marrow transplant training through a fellowship at Stanford Medical Center. Certified by the American Board of Internal Medicine in
Subscribe to Acute Myeloid Leukemia (AML)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.